English
|
正體中文
|
简体中文
|
全文筆數/總筆數 : 12340/13424 (92%)
造訪人次 : 1998296 線上人數 : 137
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
搜尋範圍
全部NHRI
免疫醫學研究中心
莊宗顯
--專利
--會議論文/會議摘要
--期刊論文
查詢小技巧:
您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
進階搜尋
主頁
‧
登入
‧
上傳
‧
說明
‧
關於NHRI
‧
管理
國家衛生研究院 NHRI
>
免疫醫學研究中心
>
莊宗顯
>
依題名瀏覽
依作者瀏覽
依日期瀏覽
依資料類型瀏覽
社群詳細資訊
簡介:
ORCID:0000-0001-8821-9813
資料載入中.....
子類別
專利
[
0
/10]
會議論文/會議摘要
[
10
/12]
期刊論文
[
76
/76]
鄰近社群
朱清良(2005-2010)
[
13
/14]
林文傑
[
20
/21]
林素珍(2008-2009)
[
2
/2]
莊懷佳
[
53
/65]
蘇郁文
[
23
/26]
謝世良
[
8
/8]
譚澤華
[
73
/87]
高承源
[
25
/29]
黃慶裕
[
10
/11]
其他
[
8
/9]
社群統計
近3年內發表的文件:14(14.29%)
含全文筆數:86(87.76%)
文件下載次數統計
下載大於0次:86(100.00%)
下載大於100次:82(95.35%)
檔案下載總次數:34081(0.60%)
最後更新時間: 2025-02-26 05:18
上傳排行
資料載入中.....
下載排行
資料載入中.....
最近上傳
CpG-寡脫氧核苷酸與免疫調節劑的組合用於癌症免疫治療
CpG-oligodeoxynucleotide compounds ...
CpG-oligodeoxynucleotide, immunogen...
CpG寡脱氧核苷酸、免疫组成物及其用途
CpG寡脱氧核苷酸、包含其的免疫组合物及制备组合物并通过其刺激免疫反应...
CPG寡脫氧核苷酸、包含其的免疫組合物及製備組合物並通過其刺激免疫反應...
CpG寡脫氧核苷酸、包含其之免疫組成物以及以其製備用於誘發免疫反應之藥...
Method of stimulating TLR9-activate...
CpG寡脱氧核苷酸、包含其的免疫组合物及组合物用于制备治疗以刺激免疫反...
CpG寡去氧核苷酸、包含其之免疫組合物及組合物用於製備治療以刺激免疫反...
跳至:
(選擇年份)
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(選擇月份)
January
February
March
April
May
June
July
August
September
October
November
December
或輸入年份:
由新到舊排序
由最舊的開始
顯示項目1-25 / 98. (共4頁)
1
2
3
4
>
>>
每頁顯示[
10
|
25
|
50
]項目
日期
題名
關聯
2024-11-18
Cooperative tumor inhibition by CpG-oligodeoxynucleotide and cyclic dinucleotide in head and neck cancer involves T helper cytokine and macrophage phenotype reprogramming
Biomedicine and Pharmacotherapy. 2024 Nov 18;181:Article number 117692.
2024-07-19
PTEN acts as a crucial inflammatory checkpoint controlling TLR9/IL-6 axis in B cells
iScience. 2024 Jul 19;27(7):Article number 110388.
2024-07-08
Adaptation of a eukaryote-like ProRS to a prokaryote-like tRNApro
Nucleic Acids Research. 2024 Jul 08;52(12):7158-7170.
2024-06-17
Tumor promoting effect of PDLIM2 downregulation involves mitochondrial ROS, oncometabolite accumulations and HIF-1alpha activation
Journal of Experimental and Clinical Cancer Research. 2024 Jun 17;43:Article number 169.
2024-05-03
CPG寡脫氧核苷酸、包含其的免疫組合物及製備組合物並通過其刺激免疫反應的方法
HK40045789/2024-05-03
2024-03-07
Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer
Signal Transduction and Targeted Therapy. 2024 Mar 07;9:Article number 64.
2024-02-27
CpG寡脱氧核苷酸、包含其的免疫组合物及制备组合物并通过其刺激免疫反应的方法
CN112263675/2024-02-27
2024-02-13
CpG-oligodeoxynucleotide compounds in combination with immune modulators for cancer immunotherapy
US11898147/2024-02-13
2023-09
GSKIP modulates cell aggregation through EMT/MET signaling rather than differentiation in SH-SY5Y human neuroblastoma cells
Journal of Cell Communication and Signaling. 2023 Sep;17(3):1039-1054.
2023-08-09
Sequence-specific targeting of C. elegans C-Ala to the D-loop of tRNA(Ala)
Journal of Biological Chemistry. 2023 Aug 9;299-302(9):Article number 105149.
2023-05-29
TLR9 and STING agonists cooperatively boost the immune response to SARS-CoV-2 RBD vaccine through an increased germinal center B cell response and reshaped T helper responses
International Journal of Biological Sciences. 2023 May 29;19(9):2897-2913.
2023-05-21
CpG-寡脫氧核苷酸與免疫調節劑的組合用於癌症免疫治療
TWI802987/2023-05-21
2023-05-11
Induction of immune responses and phosphatidylserine exposure by TLR9 activation results in a cooperative antitumor effect with a phosphatidylserine-targeting prodrug
International Journal of Biological Sciences. 2023 May 11;19(9):2648-2662.
2023-05-09
The Src-ZNRF1 axis controls TLR3 trafficking and interferon responses to limit lung barrier damage
Journal of Experimental Medicine. 2023 May 09;220(8):Article number e20220727.
2022-12
Ketamine promotes breast tumor growth in a mouse breast tumor model involving with high expression of miR-27b-3p and EGFR
Investigational New Drugs. 2022 Dec;40(6):1165-1172.
2022-11-21
Formulation of SARS-CoV-2 spike protein with CpG oligodeoxynucleotides and squalene nanoparticles modulates immunological aspects following intranasal delivery
Pharmaceutics. 2022 Nov 21;14(11):Article number 2539.
2022-07-04
Virofree, an herbal medicine-based Formula, interrupts the viral infection of delta and omicron variants of SARS-CoV-2
Frontiers in Pharmacology. 2022 Jul 04;13:Article number 905197.
2022-05-13
CpG寡脱氧核苷酸、免疫组成物及其用途
CN109593765/2022-05-13
2022-05-02
Furin and TMPRSS2 resistant spike induces robust humoral and cellular immunity against SARS-CoV-2 lethal infection
Frontiers in Immunology. 2022 May 2;13:Article number 872047.
2022-05
Sharpening up tumor microenvironment to enhance the efficacy of immune checkpoint blockade on head and neck cancer using a CpG-oligodeoxynucleotide
Cancer Immunology, Immunotherapy. 2022 May;71(5):1115-1128.
2022-03-29
CpG寡脱氧核苷酸、包含其的免疫组合物及组合物用于制备治疗以刺激免疫反应的药物的应用
CN105530957/2022-03-29
2022-03-25
Honeysuckle (Lonicera japonica) and huangqi (Astragalus membranaceus) suppress SARS-CoV-2 entry and COVID-19 related cytokine storm in vitro
Frontiers in Pharmacology. 2022 Mar 25;12:Article number 765553.
2022-02-16
Recent advances in the development of toll-like receptor agonist-based vaccine adjuvants for infectious diseases
Pharmaceutics. 2022 Feb 16;14(2):Article number 423.
2021-07-11
Therapeutic development based on the immunopathogenic mechanisms of psoriasis
Pharmaceutics. 2021 Jul 11;13(7):Article number 1064.
2021-06-29
Terminal uridyltransferase 7 regulates TLR4-triggered inflammation by controlling Regnase-1 mRNA uridylation and degradation
Nature Communications. 2021 Jun 29;12:Article number 3878.
顯示項目1-25 / 98. (共4頁)
1
2
3
4
>
>>
每頁顯示[
10
|
25
|
50
]項目
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
回饋